Clinical Trial Results:
A Single-centre, Double-blind, Double-dummy, Randomised, Crossover
Study to investigate the effect of Formoterol HFA-pMDI versus Salmeterol
HFA-pMDI on small airways physiological parameters in COPD patients.
IMPERIAL Study
Summary
|
|
EudraCT number |
2008-008656-16 |
Trial protocol |
GB |
Global completion date |
17 Sep 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jan 2017
|
First version publication date |
06 Jan 2017
|
Other versions |
|
Summary report(s) |
EudraCT No. 2008-008656-16 ICH E3 Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.